ID
20778
Beschrijving
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-Cell Lymphoma: NHL-13; ODM derived from: https://clinicaltrials.gov/show/NCT00400478
Link
https://clinicaltrials.gov/show/NCT00400478
Trefwoorden
Versies (1)
- 16-03-17 16-03-17 -
Geüploaded op
16 maart 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT00400478
Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT00400478
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Lymphoma Transformed
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0024299
- UMLS CUI [1,2]
- C0457344
Beschrijving
Secondary Malignant Neoplasm
Datatype
boolean
Alias
- UMLS CUI [1]
- C3266877
Beschrijving
Central Nervous System Involvement Evidence of
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C4050309
- UMLS CUI [1,2]
- C0332120
Beschrijving
Heart Disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0018799
Beschrijving
Creatinine measurement, serum
Datatype
boolean
Alias
- UMLS CUI [1]
- C0201976
Beschrijving
HIV Seropositivity | Hepatitis viral test positive
Datatype
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C3495836
Similar models
Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT00400478
- StudyEvent: Eligibility
C1511572 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0393022 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1318439 (UMLS CUI [2])
C3843422 (UMLS CUI [1,2])
C0035150 (UMLS CUI [1,3])
C0457344 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,2])
C3495836 (UMLS CUI [2])